“Efficacy of Dapagliflozin versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus” (2026) World Journal of Current Medical and Pharmaceutical Research, 8(2), pp. 185–189. doi:10.37022/wjcmpr.v8i2.415.